Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| USANA HEALTH SCIENCES INCUSNA · Entity 6114 | 10% owner | September 03, 2025 | September 05, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
USANA HEALTH SCIENCES INC
Report date September 03, 2025 · Filed September 05, 2025
Jointly reported with WENTZ MYRON W
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectShares owned of record by Gull Global Limited | 7,408,345 |
Reported balance
After 2025-09-03 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2025-09-03 · Gift · Disposed 145,000 · Balance 7,408,345 F1: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Gull Global Limited is directly owned 50% by Viron Company Limited and 50% by Myogen Limited, each of which is a company formed under the Commonwealth of the Bahamas and is wholly indirectly owned and controlled by Dr. Wentz. |
Filing footnotes · ownership attribution and instrument terms
F1: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Gull Global Limited is directly owned 50% by Viron Company Limited and 50% by Myogen Limited, each of which is a company formed under the Commonwealth of the Bahamas and is wholly indirectly owned and controlled by Dr. Wentz.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2018 Filed Mar 6, 2018 01:18 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 28,050 | $76.14 | $2,135,797.13 |
DisclosureSEC source: 0001179110-18-003547 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,522,053 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $75.40 to $77.35, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| March 01, 2018 Filed Mar 6, 2018 01:18 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 11,950 | $75.77 | $905,482.57 |
DisclosureSEC source: 0001179110-18-003547 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,550,103 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $75.25 to $76.50, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 22:59 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 19,167 | $76.57 | $1,467,546.27 |
DisclosureSEC source: 0001179110-18-002304 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,562,053 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $75.65 to $77.25, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| February 14, 2018 Filed Feb 16, 2018 22:59 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 34,205 | $75.70 | $2,589,198.78 |
DisclosureSEC source: 0001179110-18-002304 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,581,220 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $74.75 to $75.90, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| February 13, 2018 Filed Feb 13, 2018 23:57 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 16,134 | $75.46 | $1,217,518.43 |
DisclosureSEC source: 0001179110-18-002034 · edgar.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,615,425 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F4 · price: Weighted average price. Price range in multiple transactions was $74.95 to $75.60, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| February 12, 2018 Filed Feb 13, 2018 23:57 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 10,287 | $75.39 | $775,530.76 |
DisclosureSEC source: 0001179110-18-002034 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,631,559 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $74.70 to $76.10, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 23:57 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 1,984 | $74.78 | $148,358.76 |
DisclosureSEC source: 0001179110-18-002034 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,641,846 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $73.50 to $75.55, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| February 06, 2018 Filed Feb 7, 2018 00:37 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 27,126 | $71.00 | $1,925,940.57 |
DisclosureSEC source: 0001179110-18-001680 · edgar.xml · nonDerivative · entry 4 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,643,830 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F4 · price: Weighted average price. Price range in multiple transactions was $69.55 to $71.55, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 00:37 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 8,344 | $72.28 | $603,123.51 |
DisclosureSEC source: 0001179110-18-001680 · edgar.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,670,956 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $71.075 to $73.50, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| February 02, 2018 Filed Feb 7, 2018 00:37 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 2,753 | $74.24 | $204,389.88 |
DisclosureSEC source: 0001179110-18-001680 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,679,300 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $73.60 to $74.78, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| December 29, 2017 Filed Feb 7, 2018 00:37 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | GiftCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-001680 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,682,053 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| December 11, 2017 Filed Jun 1, 2018 01:49 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | PurchaseCommon Stock | 10,396 | $70.70 | $734,997.20 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 9 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,921,609 Read SEC document |
| December 08, 2017 Filed Jun 1, 2018 01:49 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | PurchaseCommon Stock | 824 | $70.70 | $58,256.80 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 8 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,911,213 Read SEC document |
| December 07, 2017 Filed Jun 1, 2018 01:49 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | PurchaseCommon Stock | 6,697 | $70.46 | $471,870.62 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 7 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,910,389 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F6 · price: Weighted average price. Price range in multiple transactions was $70.15 to $70.70, inclusive. Read SEC document |
| December 06, 2017 Filed Jun 1, 2018 01:49 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | PurchaseCommon Stock | 1,200 | $70.70 | $84,840.00 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 6 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,903,692 Read SEC document |
| December 04, 2017 Filed Jun 1, 2018 01:49 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 500 | $70.79 | $35,395.00 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 5 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,902,492 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F5 · price: Weighted average price. Price range in multiple transactions was $70.75 to $70.85, inclusive. Read SEC document |
| December 04, 2017 Filed Jun 1, 2018 01:49 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 6,181 | $70.44 | $435,389.64 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 4 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,902,992 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F4 · price: Weighted average price. Price range in multiple transactions was $69.75 to $70.725, inclusive. Read SEC document |
| December 01, 2017 Filed Jun 1, 2018 01:49 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 192 | $71.75 | $13,776.00 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,909,173 Read SEC document |
| December 01, 2017 Filed Jun 1, 2018 01:49 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 11,644 | $70.49 | $820,785.56 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,909,365 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F3 · price: Weighted average price. Price range in multiple transactions was $69.95 to $70.85, inclusive. Read SEC document |
| December 01, 2017 Filed Jun 1, 2018 01:49 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 600 | $69.21 | $41,526.00 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,921,009 F1 · price: Weighted average price. Price range in multiple transactions was $68.95 to $69.60, inclusive. F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| November 22, 2017 Filed Nov 27, 2017 21:30 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 45,216 | $66.44 | $3,004,146.52 |
DisclosureSEC source: 0001179110-17-014624 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,694,053 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $66.00 to $66.772, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| November 21, 2017 Filed Nov 21, 2017 22:47 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 117,270 | $66.53 | $7,801,797.20 |
DisclosureSEC source: 0001179110-17-014441 · edgar.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,739,269 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F4 · price: Weighted average price. Price range in multiple transactions was $66.00 to $67.80, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| November 20, 2017 Filed Nov 21, 2017 22:47 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 39,751 | $66.11 | $2,628,053.89 |
DisclosureSEC source: 0001179110-17-014441 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,856,539 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $66.00 to $66.275, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| November 17, 2017 Filed Nov 21, 2017 22:47 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 7,895 | $66.03 | $521,277.64 |
DisclosureSEC source: 0001179110-17-014441 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,896,290 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $66.00 to $66.05, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| November 16, 2017 Filed Nov 16, 2017 22:20 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 80,172 | $66.06 | $5,295,857.67 |
DisclosureSEC source: 0001179110-17-014212 · edgar.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,904,185 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $66.00 to $66.3875, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| November 15, 2017 Filed Nov 16, 2017 22:20 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 11,835 | $66.07 | $781,959.75 |
DisclosureSEC source: 0001179110-17-014212 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,984,357 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $66.05 to $66.10, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| November 14, 2017 Filed Nov 16, 2017 22:20 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 9,922 | $66.00 | $654,852.00 |
DisclosureSEC source: 0001179110-17-014212 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,996,192 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| November 13, 2017 Filed Nov 13, 2017 21:44 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 5,304 | $66.01 | $350,125.53 |
DisclosureSEC source: 0001179110-17-014030 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,006,114 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F3 · price: Weighted average price. Price range in multiple transactions was $66.00 to $66.05, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 21:44 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 1,985 | $66.01 | $131,033.82 |
DisclosureSEC source: 0001179110-17-014030 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,011,418 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F3 · price: Weighted average price. Price range in multiple transactions was $66.00 to $66.05, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| November 02, 2017 Filed Nov 2, 2017 22:52 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 22,893 | $65.02 | $1,488,605.88 |
DisclosureSEC source: 0001179110-17-013677 · edgar.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,013,403 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F5 · price: Weighted average price. Price range in multiple transactions was $64.40 to $65.40, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| November 01, 2017 Filed Nov 2, 2017 22:52 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 17,107 | $65.42 | $1,119,074.93 |
DisclosureSEC source: 0001179110-17-013677 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,036,296 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F4 · price: Weighted average price. Price range in multiple transactions was $64.85 to $65.85, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| October 31, 2017 Filed Nov 2, 2017 22:52 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 3,292 | $66.01 | $217,301.96 |
DisclosureSEC source: 0001179110-17-013677 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,053,403 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $66.00 to $66.10, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| October 30, 2017 Filed Oct 30, 2017 20:54 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 21,209 | $66.11 | $1,402,033.67 |
DisclosureSEC source: 0001179110-17-013533 · edgar.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,056,695 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F4 · price: Weighted average price. Price range in multiple transactions was $66.00 to $67.025, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| October 27, 2017 Filed Oct 30, 2017 20:54 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 11,363 | $67.26 | $764,240.15 |
DisclosureSEC source: 0001179110-17-013533 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,077,904 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $67.25 to $67.35, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| October 26, 2017 Filed Oct 30, 2017 20:54 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 60,871 | $67.39 | $4,101,895.82 |
DisclosureSEC source: 0001179110-17-013533 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,089,267 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $66.50 to $68.275, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| October 03, 2017 Filed Oct 4, 2017 15:53 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 13,851 | $57.59 | $797,744.19 |
DisclosureSEC source: 0001179110-17-013066 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,150,138 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $56.80 to $58.00, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 15:53 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 26,149 | $57.51 | $1,503,849.91 |
DisclosureSEC source: 0001179110-17-013066 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,163,989 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $56.375 to $57.80, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| September 15, 2017 Filed Sep 15, 2017 21:28 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 28,788 | $57.19 | $1,646,515.27 |
DisclosureSEC source: 0001179110-17-012335 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,190,138 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $57.00 to $57.45, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| September 14, 2017 Filed Sep 14, 2017 21:44 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 34,226 | $57.51 | $1,968,258.54 |
DisclosureSEC source: 0001179110-17-012299 · edgar.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,218,926 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F4 · price: Weighted average price. Price range in multiple transactions was $57.40 to $57.65, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| September 13, 2017 Filed Sep 14, 2017 21:44 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 18,861 | $57.39 | $1,082,421.47 |
DisclosureSEC source: 0001179110-17-012299 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,253,152 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $57.20 to $58.00, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 21:44 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 26,207 | $57.91 | $1,517,584.47 |
DisclosureSEC source: 0001179110-17-012299 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,272,013 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $57.80 to $58.35, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| September 05, 2017 Filed Sep 6, 2017 18:02 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 28,004 | $58.23 | $1,630,560.90 |
DisclosureSEC source: 0001179110-17-012057 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,298,220 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F4 · price: Weighted average price. Price range in multiple transactions was $57.625 to $58.90, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| September 05, 2017 Filed May 26, 2018 00:28 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | GiftCommon Stock | 136,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-031180 · tv495185_4.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,025,753 Read SEC document |
| September 01, 2017 Filed Sep 6, 2017 18:02 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 11,996 | $58.83 | $705,740.27 |
DisclosureSEC source: 0001179110-17-012057 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,326,224 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F3 · price: Weighted average price. Price range in multiple transactions was $58.50 to $59.30, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| August 02, 2017 Filed Aug 2, 2017 21:39 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 14,533 | $56.71 | $824,154.80 |
DisclosureSEC source: 0001179110-17-010998 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,338,220 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F4 · price: Weighted average price. Price range in multiple transactions was $56.15 to $57.40, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| August 01, 2017 Filed Aug 2, 2017 21:39 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 25,467 | $56.52 | $1,439,351.55 |
DisclosureSEC source: 0001179110-17-010998 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,352,753 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F3 · price: Weighted average price. Price range in multiple transactions was $56.10 to $57.20, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| July 05, 2017 Filed Jul 6, 2017 18:09 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 18,331 | $64.11 | $1,175,220.57 |
DisclosureSEC source: 0001179110-17-010162 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,378,220 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F4 · price: Weighted average price. Price range in multiple transactions was $63.68 to $64.70, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| July 03, 2017 Filed Jul 6, 2017 18:09 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 21,669 | $64.18 | $1,390,701.25 |
DisclosureSEC source: 0001179110-17-010162 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,396,551 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F3 · price: Weighted average price. Price range in multiple transactions was $64.00 to $64.55, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| June 02, 2017 Filed Jun 2, 2017 21:24 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 13,731 | $65.30 | $896,617.82 |
DisclosureSEC source: 0001179110-17-008459 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,418,220 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F4 · price: Weighted average price. Price range in multiple transactions was $64.75 to $65.80, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 21:24 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 26,269 | $64.82 | $1,702,824.88 |
DisclosureSEC source: 0001179110-17-008459 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,431,951 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F3 · price: Weighted average price. Price range in multiple transactions was $64.13 to $65.20, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.